The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2-Reference-Cited by-同舟云学术

The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2

Published:2023-10 Issue: Volume:957 Page:175969
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Zheng Xi,Su Fuxiang,Lei Ming,Li Jingyuan,Zhang Chenyang,Zhang Yujia,Wei Ming,Li Wei,Chen Sichong,Liu Yunzhu,Gao Qinghua,Hao Liying^ORCID

Funder

National Natural Science Foundation of China

Southwest Medical University Institute of Cardiovascular Research

Publisher

Elsevier BV

Subject

Pharmacology

Reference52 articles.

1. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy;Ago;Cell,2008

2. CaMKII in myocardial hypertrophy and heart failure;Anderson;J. Mol. Cell. Cardiol.,2011

3. Physiological and unappreciated roles of CaMKII in the heart;Beckendorf;Basic Res. Cardiol.,2018

4. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice;Bendall;Circulation,2002

5. Redox signaling in cardiac physiology and pathology;Burgoyne;Circ. Res.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib as a CaMKII inhibitor for treatment of cardiac arrhythmias: Applications and prospects;Heart Rhythm;2024-08

2. Euphorbiasteroid Induces Apoptosis as Well as Autophagy through Modulating SHP-1/STAT3 Pathway in Hepatocellular Carcinoma Cells;International Journal of Molecular Sciences;2023-09-05